MDxHealth SA (MDXH) Tops Q2 EPS

MDxHealth SA (NASDAQ: MDXH) reported Q2 EPS of ($0.12), $0.45 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $6.41 million.

GUIDANCE:

MDxHealth SA sees Q3 2022 revenue of $40-42 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c